Download Free Sample Report

The Asia Pacific Tranexamic Acid market size was valued at US$ 156.3 million in 2024 and is projected to reach US$ 204.8 million by 2030, at a CAGR of 4.6% during the forecast period 2024-2030.
Tranexamic acid is a synthetic amino acid derivative used as an antifibrinolytic medication to treat or prevent excessive blood loss in various medical conditions and surgical procedures.
The Asia Pacific tranexamic acid market is growing steadily, driven by increasing surgical procedures and awareness of its effectiveness in managing bleeding disorders. Japan leads with a 30% market share, followed by China at 25% and India at 20%. In 2023, surgical applications accounted for 55% of total consumption, with gynecological uses at 25% and trauma management at 15%. The market experienced a 7% growth in demand from the cosmetic industry for skin whitening applications. Key players include Daiichi Sankyo (Japan) and Emcure Pharmaceuticals (India), holding a combined 35% market share in the region. The industry is investing in novel formulations, with a 12% increase in R&D spending on extended-release preparations in 2023. Challenges include patent expirations, leading to a 15% increase in generic competition. The COVID-19 pandemic has driven a 10% rise in demand for managing complications in severe cases. The market is benefiting from expanding healthcare access in developing countries, with an 8% growth in rural healthcare initiatives incorporating tranexamic acid in emergency kits.

Report Includes

This report is an essential reference for who looks for detailed information on Asia Pacific Tranexamic Acid . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Tranexamic Acid , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.

This report aims to provide a comprehensive presentation of the Asia Pacific Tranexamic Acid , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid . This report contains market size and forecasts of Tranexamic Acid in Asia Pacific, including the following market information:
We surveyed the Tranexamic Acid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

by Country

•    China
•    India
•    Japan
•    South Korea
•    Australia
•    Thailand
•    Indonesia

by Products type:

•    USP25
•    BP2000
•    Other

by Application:

•    Trauma
•    Craniocerebral Trauma
•    Menorrhagia
•    Postpartum Hemorrhage
•    Surgery
•    Other Treatment
•    Whitening Cosmetics

key players include: (At least 8-10 companies included)

•    Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd.
•    Shanxi Kangbao Biological Product Co., Ltd
•    Nippon Pharmaceutical Co., Ltd
•    Hikma Pharmaceuticals PLC
•    Olon S.p.A.
•    Zhejiang Huayi Pharmaceutical Co., Ltd.
•    Sanghai Lonyer Fuels Co., Ltd
•    Zydus Cadila
•    Emcure Pharmaceuticals Ltd.
•    Micro Labs Ltd

Including or excluding key companies relevant to your analysis.

Competitor Analysis

The report also provides analysis of leading market participants including:
•    Key companies Tranexamic Acid revenues in Asia Pacific market, 2019-2024 (Estimated), ($ millions)
•    Key companies Tranexamic Acid revenues share in Asia Pacific market, 2023 (%)
•    Key companies Tranexamic Acid sales in Asia Pacific market, 2019-2024 (Estimated),
•    Key companies Tranexamic Acid sales share in Asia Pacific market, 2023 (%)

Key Points of this Report:
•    The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
•    The report covers Asia Pacific and country-wise market of Tranexamic Acid
•    It describes present situation, historical background and future forecast
•    Comprehensive data showing Tranexamic Acid capacities, production, consumption, trade statistics, and prices in the recent years are provided
•    The report indicates a wealth of information on Tranexamic Acid manufacturers
•    Tranexamic Acid forecast for next five years, including market volumes and prices is also provided
•    Raw Material Supply and Downstream Consumer Information is also included
•    Any other user's requirements which is feasible for us

Reasons to Purchase this Report:
•    Analyzing the outlook of the market with the recent trends and SWOT analysis
•    Market dynamics scenario, along with growth opportunities of the market in the years to come
•    Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
•    Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
•    Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
•    Distribution Channel sales Analysis by Value
•    Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
•    Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
•    1-year analyst support, along with the data support in excel format.